Author

A. Recht

Institution: Beth Israel Deaconess Medical Center

Observed institutions: Beth Israel Deaconess Medical Center, Harvard University

OpenAlex ID: A5020130075

Abstract GS1-04: Tumor infiltrating lymphocytes (TILs) and pathologic complete response (pCR) in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): secondary results from the ECOG-ACRIN EA1181/CompassHER2 pCR trial

2026 · S. S. Badve, F. Zhao, et al. · Clinical Cancer Research

Cost-Effectiveness Analysis of Ultra-Short Whole Breast Radiation Therapy Alone vs. Endocrine Only or Combined Treatment for Low-Risk ER-Positive Early-Stage Breast Cancer in Women Age 70 and Older

2022 · M.C. Ward, A. Recht, et al. · International Journal of Radiation Oncology*Biology*Physics

Impact of Sequencing of Postmastectomy Radiotherapy and Breast Reconstruction on Timing and Rate of Complications and Patient Satisfaction

2009 · T.A. Adesiyun, B.T. Lee, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 3

Citation count:

H-index:

I10-index: